FKBPL and preeclampsia: FKBPL has emerged as a new predictive and diagnostic biomarker and a therapeutic target of preeclampsia (Masoumeh Ghorbanpour et al., 2023; Ghorbanpour et al., 2023; McNally et al., 2021; Todd et al., 2021).